Key result
ZASP myofibrillar myopathy warrants inclusion in differential diagnoses for late-onset distal or autosomal dominant weakness.
Case Report (n=1)
ZASP myofibrillar myopathy can present with a purely distal lower limb phenotype, and affected patients should be tested for cardiomyopathy.
Distal myopathy warrants ZASP MFM genetic testing; extends recognized MFM phenotypes but leaves broader adoption hypothesis-generating.
Myopathies typically present with proximal or generalised muscle weakness, but it is important for clinicians to recognise they may also have other distributions. This paper describes a case of distal myopathy that was confirmed genetically as ZASP (Z-band alternatively spliced PDZ motif-containing protein) myofibrillar myopathy (MFM). MFMs are particularly topical because the genetic basis of several have recently been established, enabling diagnosis of conditions previously labelled 'idiopathic myopathy', and shedding new light on their pathophysiology. This paper describes a purely distal lower limb phenotype of ZASP MFM, the pathophysiology of ZASP and other MFMs, and the differential diagnosis of late-onset distal symmetrical weakness. The case includes several learning points: ZASP MFM is a new diagnosis; it should be included in differential diagnoses for late-onset myopathy, especially if there is a distal pattern or autosomal dominant inheritance; testing for cardiomyopathy is recommended, and a genetic test is now available.
No takes yet. Share an insight, caveat, or question.
Newby et al. (2015) conducted a case report in ZASP myofibrillar myopathy (n=1). A case of late-onset distal myopathy was genetically confirmed as ZASP myofibrillar myopathy, highlighting the need to include it in differential diagnoses for distal or autosomal dominant weakness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: